RCUS - Financial Reports List - Arcus Biosciences, Inc. - IntrinsicAlpha

Arcus Biosciences, Inc. RCUS

Healthcare - Biotechnology - NYSE - US

$ 8.09

-2.16 %

$ 856 M

Market Cap

-2.46

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-16.13%	-16.05%	-13.19%
Annual Report	FY	10-K	2024-12-31	120.51%	7.82%	2.94%
Quarterly Report	Q3	8-K	2024-09-30	50.00%	-29.58%	-31.25%
Quarterly Report	Q2	8-K	2024-06-30	34.48%	-24.00%	-27.71%
Quarterly Report	Q1	8-K	2024-03-31	480.00%	95.00%	81.40%
Quarterly Report	Q4	8-K	2023-12-31	8885.51%	-20.90%	-22.97%
Annual Report	FY	10-K	2023-12-31	4.46%	-14.98%	-21.43%
Quarterly Report	Q3	8-K	2023-09-30	-4.71%	-17.47%	-15.28%
Quarterly Report	Q2	8-K	2023-06-30	8.37%	-16.67%	-20.32%
Quarterly Report	Q1	8-K	2023-03-31	38.85%	-17.66%	-28.01%

1